Literature DB >> 4119511

Multiple sclerosis unaffected by azathioprine in pilot study.

D Silberberg, R Lisak, B Zweiman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4119511     DOI: 10.1001/archneur.1973.00490210090017

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  9 in total

1.  Prolonged azathioprine treatment of non-remitting multiple sclerosis.

Authors:  J A Rosen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-04       Impact factor: 10.154

Review 2.  Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  I R Mackay; P R Carnegie; A S Coates
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

3.  Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.

Authors:  D A Drachman; P Y Paterson; R T Schmidt; R F Spehlmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-06       Impact factor: 10.154

4.  Antimyelin antibody in multiple sclerosis: no change during immunosuppression.

Authors:  L D Wilkerson; R P Lisak; B Zweiman; D H Silberberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-09       Impact factor: 10.154

5.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 6.  Azathioprine for multiple sclerosis.

Authors:  I Casetta; G Iuliano; G Filippini
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

7.  Effectiveness of azathioprine treatment in multiple sclerosis.

Authors:  L Fratiglioni; G F Siracusa; M P Amato; D Sità; L Amaducci
Journal:  Ital J Neurol Sci       Date:  1988-06

8.  Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.

Authors:  R E Gonsette; L Demonty; P Delmotte
Journal:  J Neurol       Date:  1977-02-17       Impact factor: 4.849

Review 9.  Azathioprine. Safety profile in multiple sclerosis patients.

Authors:  L La Mantia; N Mascoli; C Milanese
Journal:  Neurol Sci       Date:  2007-12       Impact factor: 3.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.